A New Chapter for Walgreens as It Exits Public Markets
Published on 10/03/2025 at 13:18 | Redaktion boerse-global.de
After nearly a century as a publicly traded company, Walgreens Boots Alliance has concluded its stock market journey. The landmark acquisition by private equity firm Sycamore Partners, valued at approximately $10 billion, was finalized on August 28, delisting the iconic pharmacy chain from the Nasdaq.
Shareholders received a cash payment of $11.45 per share, representing a significant 29% premium over the stock price from December 2024. An additional incentive of up to $3 per share is contingent on the successful divestiture of healthcare divisions, including VillageMD and Summit Health.
The decision to go private follows a period of substantial financial difficulty for the retailer. The company reported a staggering $8.6 billion loss for 2024, nearly triple the deficit from the previous year. This performance precipitated a dramatic... Read more...
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
